| | | | | |
UP Wheels Up Experience Inc. | $7,0500 | -1,95% | $261,07M | $134,55K | |
NUS NuSkin Enterprises, Inc. | $5,5200 | +3,76% | $260,71M | $449,03K | |
AIRO AIRO Group Holdings, Inc. Common Stock | $8,6400 | +3,10% | $260,68M | $690,63K | |
ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | $3,5850 | +0,14% | $260,54M | $407,13K | |
| $2,9100 | -2,35% | $259,95M | $708,99K | |
DEFT Defi Technologies, Inc. | $0,54020 | -3,88% | $259,84M | $3,73M | |
FACT FACT II Acquisition Corp. Class A Ordinary Shares | $10,6600 | +0,00% | $259,75M | $12,75K | |
| $3,3600 | +4,67% | $259,24M | $450,36K | |
| $16,6500 | -12,80% | $258,92M | $102,77K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,3700 | -0,88% | $258,44M | $353,26K | |
TWFG TWFG, Inc. Common Stock | $20,5700 | +3,42% | $258,25M | $373,62K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | $5,5500 | +1,46% | $257,83M | $275,50K | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | $10,6400 | -0,09% | $257,70M | $36,66K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | $10,6100 | -0,09% | $257,57M | $30,04K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | $10,6300 | +0,00% | $257,32M | $107,00 | |
